Gene Editing Therapeutics 

Accelerating CRISPR-based drug development


Solid phase synthesis of therapeutic sgRNAs

  • Variety of chemical modifications
  • Scalable manufacturing process up to GMP
  • Unprecidented purity

Superior biological editing efficiency

Advanced analytics

  • Release by ion-pairing reversed phase HPLC coupled to electrospray MS (IP-RP-HPLC-ESI-MS)
  • Capillary electrophoresis

We offer guidance, beyond manufacturing, through the entire drug development process

  • Bioanalysis of sgRNA and Cas9 mRNA in blood and tissue (under GLP/GCP)
  • Support of delivery/formulation
  • Editing analysis
  • Consultancy based on our long-standing experience in the field of nucleic acid therapeutics